New progress has been made in the development of novel self-assembled trivalent nanoparticle vaccines against fowl adenovirus (FAdV).
The research team led by Kuan Zhao from Hebei Agricultural University has made new advances in developing a novel self-assembled trivalent nanoparticle vaccine against fowl adenovirus. The related research findings have been published in the internationally renowned journal Journal of Nanobiotechnology (IF = 15, Q1 journal).
This study provides an important basis for developing next-generation FAdV nanoparticle vaccines and formulating prevention and control strategies against infections caused by different FAdV serotypes.
Research Objectives and Background
Fowl adenovirus (FAdV) is one of the most common infectious pathogens in the poultry farming industry. It is a non-enveloped virus with a double-stranded DNA genome, and its viral particles have a diameter of approximately 70–90 nm. FAdV-4, FAdV-8b, and FAdV-11 have become prevalent in China, resulting in persistently high mortality rates in chicken flocks. Vaccination remains the primary strategy for preventing and controlling FAdV infection. Given that FAdV comprises multiple serotypes with limited cross-protective effects among them, no trivalent subunit vaccine targeting FAdV-4, FAdV-8b, and FAdV-11 has been reported to date.
Subunit vaccines are primarily composed of immunogenic capsid proteins. The FAdV capsid consists of hexon, penton, and fiber proteins. Fiber proteins protrude from the surface of the capsid and facilitate viral entry by binding to cellular receptors. Studies have shown that FAdV-1, FAdV-4, and FAdV-10 each carry two fiber protein genes (fiber protein 1 and fiber protein 2), whereas other serotypes carry only one. Fiber proteins consist of tail, shaft, and knob domains, which are arranged sequentially from the N-terminus to the C-terminus. The knob domain is the functional region of the fiber protein and is also an epitope-rich site capable of eliciting strong immune responses. Therefore, the knob domain of the fiber protein is an ideal antigen for developing multivalent subunit vaccines, as it allows for straightforward recombinant construction and expression.
When antigens (viral capsid proteins) can self-assemble into highly ordered virus-like particles (VLPs), immune responses are significantly enhanced, resulting in vaccines with high protective efficacy. However, the antigens of FAdV subunit vaccines cannot spontaneously assemble into nanoparticles. In such cases, these antigens can be displayed on self-assembling protein platforms to produce nanoparticle vaccines. This approach can significantly enhance the immunogenicity of antigens, thereby inducing stronger and more sustained neutralizing antibody titers and providing superior protective efficacy.
Research Methods
The research team constructed a trivalent nanoparticle vaccine capable of simultaneously providing protection against FAdV-4, FAdV-8b, and FAdV-11. The safety and efficacy of this trivalent nanoparticle vaccine were evaluated through protein expression analysis, physicochemical characterization, and in vivo immunization and challenge experiments.
Experiments using Aniview
In the study, to verify the biodistribution of the nanoparticle vaccine and the trivalent antigen 4-8-11 D in chickens, the research team labeled the samples with CY5 and monitored them using the AniView SE small animal in vivo imaging system from Guangzhou Biolight Biotechnology Co., Ltd.
Research Results
The results showed that, compared with 4-8-11D, the nanoparticle vaccine 4-8-11 NPs prolonged antigen retention at the injection site. Ex vivo imaging of the spleen also indicated that the nanoparticle vaccine 4-8-11 NPs could persist in the body for a longer period.
These findings provide an important basis for developing next-generation FAdV nanoparticle vaccines and formulating prevention and control strategies against infections caused by different FAdV serotypes.
Doi:10.1186/s12951-026-04875-4
